SCORE Study Report 3. Study Design and Baseline Characteristics

Ophthalmology

Volumn 116, Issue 9, 2009, Pages

  Ip, Michael S ^a   Oden, Neal L ^b   Scott, Ingrid U ^c   VanVeldhuisen, Paul C ^b   Blodi, Barbara A ^a   Figueroa, Maria ^b   Antoszyk, Andrew ^d   Elman, Michael ^e  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b EMMES CORPORATION   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d Charlotte Eye Ear Nose/Throat Ass   (United States)

^e Elman Retina Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GATIFLOXACIN; LIDOCAINE; TRIAMCINOLONE; TRIVARIS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE DURATION; EYE REFRACTION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; HYPERTENSION; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA EDEMA; RETREATMENT; SLIT LAMP; STATISTICAL ANALYSIS; VISUAL ACUITY;

EID: 69249229571     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.03.022     Document Type: Article

References (34)

1. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98 (1984) 271-282
2. Central Vein Occlusion Study Group. Baseline and early natural history report. Arch Ophthalmol 111 (1993) 1087-1095
3. Klein R., Klein B.E., Moss S.E., and Meuer S.M. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98 (2000) 133-141 discussion 141-3
4. Mitchell P., Smith W., and Chang A. Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Arch Ophthalmol 114 (1996) 1243-1247
5. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report. Ophthalmology 102 (1995) 1425-1433
6. Ai E., and Yang S.S. Venous occlusive disease: the latest in current management. Retina 26 suppl (2006) S63-S64
7. Hayreh S.S. Venous occlusive disease: management 25 years ago. Retina 26 suppl (2006) S51-S62
8. Opremcak E.M., and Bruce R.A. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 19 (1999) 1-5
9. Opremcak E.M., Rehmar A.J., Ridenour C.D., and Kurz D.E. Radial optic neurotomy for central retinal vein occlusion: 117 consecutive cases. Retina 26 (2006) 297-305
10. Lit E.S., Tsilimbaris M., Gotzaridis E., and D'Amico D.J. Lamina puncture: pars plana optic disc surgery for central retinal vein occlusion. Arch Ophthalmol 120 (2002) 495-499
11. Elman M.J., Raden R.Z., and Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 99 (2001) 219-221
12. Lam H.D., and Blumenkranz M.S. Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection, and photocoagulation. Am J Ophthalmol 134 (2002) 609-611
13. Bynoe L.A., Hutchins R.K., Lazarus H.S., and Friedberg M.A. Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons. Retina 25 (2005) 625-632
14. McAllister I.L., Douglas J.P., Constable I.J., and Yu D.Y. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 126 (1998) 219-229
15. Mandelcorn M.S., and Nrusimhadevara R.K. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina 24 (2004) 348-355
16. Iturralde D., Spaide R.F., Meyerle C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26 (2006) 279-284
17. Glacet-Bernard A., Coscas G., Chabanel A., et al. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 118 (1994) 421-429
18. Rehak J., and Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 33 (2008) 111-131
19. Flynn Jr. H.W., and Scott I.U. Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials. Arch Ophthalmol 123 (2005) 258-259
20. Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115 (1997) 486-491
21. Central Vein Occlusion Study Group. Central vein occlusion study of photocoagulation therapy: baseline findings. Online J Curr Clin Trials (1993) Oct 14;Doc No 95
22. Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol 116 (1993) 286-296
23. Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 114 (1996) 545-554
24. Manual of Policies and Procedures (MOPP) for the Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study, Version 4.0 (2008), National Eye Institute, Bethesda, MD 4-1-4-8; 6-1-6-10. NTIS PB2008-106870
25. Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study, Version 7.0 (2008), National Eye Institute, Bethesda, MD 24-47; 54-65. NTIS PB2008-113743
26. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. Am J Ophthalmol 131 (2001) 167-175
27. Marcus R., Peritz E., and Gabriel K.R. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 63 (1976) 655-660
28. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75 (1988) 800-802
29. McIntosh R.L., Mohamed Q., Saw S.M., and Wong T.Y. Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 114 (2007) 835-854
30. Mohamed Q., McIntosh R.L., Saw S.M., and Wong T.Y. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 114 (2007) 507-519 524
31. Fox C.S., Pencina M.J., Meigs J.B., et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 113 (2006) 2914-2918
32. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
33. Hajjar I., Kotchen J.M., and Kotchen T.A. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health 27 (2006) 465-490
34. Fields L.E., Burt V.L., Cutler J.A., et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44 (2004) 398-404